Pediatric Asthma Treatment Global Market Report 2025

Description

Pediatric asthma treatment involves medical care and therapeutic approaches aimed at managing and alleviating asthma symptoms in children. This includes medications, lifestyle changes, and monitoring techniques to reduce inflammation, prevent asthma attacks, and enhance respiratory function.

The primary types of pediatric asthma treatment include long-term control medications, quick-relief medications, and other categories. Long-term control medications are drugs taken daily over a prolonged period to decrease inflammation, prevent symptoms, and maintain stable lung function. This group includes inhaled corticosteroids, long-acting beta agonists, leukotriene modifiers, antihistamines, and biologics. These medications are administered via various routes such as oral, nasal, and injectable. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are used in different settings including hospitals, clinics, home care, and other healthcare environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pediatric asthma treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric asthma treatment market statistics, including pediatric asthma treatment global market size, regional shares, competitors with pediatric asthma treatment market share, detailed pediatric asthma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric asthma treatment industry. The pediatric asthma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric asthma treatment market size has grown strongly in recent years. It will grow from $11.03 billion in 2024 to $11.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing incidence of childhood asthma, heightened awareness of respiratory disorders in children, a rise in air pollution and environmental allergens, growing healthcare spending on pediatric care, and awareness campaigns led by NGOs and healthcare organizations focused on asthma.

The pediatric asthma treatment market size is expected to see strong growth in the next few years. It will grow to $14.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth projected for the forecast period can be attributed to the rising prevalence of allergic disorders in children, the expansion of biologic therapies for severe pediatric asthma, increased investments in pediatric drug development, a growing focus on personalized and precision medicine, and the expanding middle-class population with access to private healthcare. Key trends expected during this period include the development of pediatric-friendly biologic therapies, creation of rapid allergen identification tools, integration of electronic health records, innovations in inhaler formulations, and advances in immunotherapy for asthma.

The rising prevalence of respiratory infections is expected to drive growth in the pediatric asthma treatment market going forward. Respiratory infections are illnesses caused by viruses, bacteria, or other pathogens that impact the respiratory tract, including the nose, throat, airways, and lungs. This increase is mainly attributed to rising air pollution, as exposure to pollutants like particulate matter and nitrogen dioxide weakens the respiratory system, making individuals more vulnerable to infections. Pediatric asthma treatments help reduce the frequency and severity of respiratory infections by improving airway function and decreasing inflammation, thereby lowering susceptibility to infectious triggers. For example, according to the Australian Institute of Health and Welfare, a government agency in Australia, chronic obstructive pulmonary disease accounted for 3.6% of the total disease burden and represented 50% of the total burden of respiratory conditions in 2023. Additionally, an estimated 638,000 people (2.5% of the population) in Australia were living with chronic obstructive pulmonary disease in 2022. Hence, the rising incidence of respiratory infections is fueling the growth of the pediatric asthma treatment market.

Key companies in the pediatric asthma treatment market are focusing on innovative therapies, such as monoclonal antibodies, to target and reduce airway inflammation in children. Monoclonal antibodies are laboratory-produced proteins designed to mimic the immune system's ability to combat harmful pathogens by specifically targeting certain cells or substances. For instance, in April 2024, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, received approval from the U.S. Food and Drug Administration for FASENRA (benralizumab) as an add-on maintenance treatment for children aged 6 to 11 years with severe asthma characterized by an eosinophilic phenotype. This antibody aims to reduce asthma exacerbations and improve symptom control by targeting and eliminating eosinophils. Fasenra is administered by subcutaneous injection once every four weeks for the first three doses, followed by once every eight weeks, with pediatric dosing adjusted according to body weight.

In January 2025, Molex LLC, a US-based consumer electronics company, acquired Vectura Group plc for an undisclosed sum. Through this acquisition, Molex LLC intends to expand its inhalation drug delivery capabilities and reinforce its position as a leading provider of comprehensive solutions for respiratory and non-respiratory therapies. Vectura Group Services Limited is a UK-based company developing a pediatric asthma treatment, a smart budesonide delivery system known as VR647.

Major players in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd., and ECU Health.

North America was the largest region in the pediatric asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric asthma treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric asthma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric asthma treatment market consists of sales of nebulizers and soft-mist inhalers, oral medications, biologic injectables, and smart monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Asthma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric asthma treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Long-Term Control Medications; Quick-Relief Medications; Other Types
2) By Drug Class: Inhaled Corticosteroids; Long-Acting Beta Agonists; Leukotriene Modifiers; Antihistamines; Biologics
3) By Route Of Administration: Oral Route; Nasal Route; Injectable Route
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals; Clinics; Home Care; Other End users
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids; Leukotriene Modifiers; Long-Acting Beta Agonists; Combination Inhalers; Biologic Therapies
2) By Quick-Relief Medications: Short-Acting Beta Agonists; Anticholinergics; Systemic Corticosteroids
3) By Other Types: Immunotherapy; Methylxanthines; Alternative Therapies
Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Amgen Inc.; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; Genentech Inc.; Chiesi Farmaceutici S.p.A; Dr. Reddy's Laboratories Ltd; Cipla Ltd; Lupin Limited; Zydus Lifesciences Ltd.; ECU Health.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37097

1. Executive Summary

2. Pediatric Asthma Treatment Market Characteristics

3. Pediatric Asthma Treatment Market Trends And Strategies

4. Pediatric Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pediatric Asthma Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pediatric Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pediatric Asthma Treatment Market Growth Rate Analysis
5.4. Global Pediatric Asthma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pediatric Asthma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pediatric Asthma Treatment Total Addressable Market (TAM)

6. Pediatric Asthma Treatment Market Segmentation

6.1. Global Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-Term Control Medications
Quick-Relief Medications
Other Types
6.2. Global Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids
Long-Acting Beta Agonists
Leukotriene Modifiers
Antihistamines
Biologics
6.3. Global Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Route
Nasal Route
Injectable Route
6.4. Global Pediatric Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Pediatric Asthma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care
Other End users
6.6. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids
Leukotriene Modifiers
Long-Acting Beta Agonists
Combination Inhalers
Biologic Therapies
6.7. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta Agonists
Anticholinergics
Systemic Corticosteroids
6.8. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunotherapy
Methylxanthines
Alternative Therapies

7. Pediatric Asthma Treatment Market Regional And Country Analysis

7.1. Global Pediatric Asthma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pediatric Asthma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Asthma Treatment Market

8.1. Asia-Pacific Pediatric Asthma Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Asthma Treatment Market

9.1. China Pediatric Asthma Treatment Market Overview
9.2. China Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Asthma Treatment Market

10.1. India Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Asthma Treatment Market

11.1. Japan Pediatric Asthma Treatment Market Overview
11.2. Japan Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Asthma Treatment Market

12.1. Australia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Asthma Treatment Market

13.1. Indonesia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Asthma Treatment Market

14.1. South Korea Pediatric Asthma Treatment Market Overview
14.2. South Korea Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Asthma Treatment Market

15.1. Western Europe Pediatric Asthma Treatment Market Overview
15.2. Western Europe Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Asthma Treatment Market

16.1. UK Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Asthma Treatment Market

17.1. Germany Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Asthma Treatment Market

18.1. France Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Asthma Treatment Market

19.1. Italy Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Asthma Treatment Market

20.1. Spain Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Asthma Treatment Market

21.1. Eastern Europe Pediatric Asthma Treatment Market Overview
21.2. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Asthma Treatment Market

22.1. Russia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Asthma Treatment Market

23.1. North America Pediatric Asthma Treatment Market Overview
23.2. North America Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Asthma Treatment Market

24.1. USA Pediatric Asthma Treatment Market Overview
24.2. USA Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Asthma Treatment Market

25.1. Canada Pediatric Asthma Treatment Market Overview
25.2. Canada Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Asthma Treatment Market

26.1. South America Pediatric Asthma Treatment Market Overview
26.2. South America Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Asthma Treatment Market

27.1. Brazil Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Asthma Treatment Market

28.1. Middle East Pediatric Asthma Treatment Market Overview
28.2. Middle East Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Asthma Treatment Market

29.1. Africa Pediatric Asthma Treatment Market Overview
29.2. Africa Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Asthma Treatment Market Competitive Landscape And Company Profiles

30.1. Pediatric Asthma Treatment Market Competitive Landscape
30.2. Pediatric Asthma Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Asthma Treatment Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. Takeda Pharmaceutical Company Limited
31.3. Amgen Inc.
31.4. Boehringer Ingelheim International GmbH
31.5. Viatris Inc.
31.6. Teva Pharmaceutical Industries Limited
31.7. Regeneron Pharmaceuticals Inc.
31.8. Sun Pharmaceutical Industries Limited
31.9. Genentech Inc.
31.10. Chiesi Farmaceutici S.p.A
31.11. Dr. Reddy's Laboratories Ltd
31.12. Cipla Ltd
31.13. Lupin Limited
31.14. Zydus Lifesciences Ltd.
31.15. ECU Health

32. Global Pediatric Asthma Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Asthma Treatment Market

34. Recent Developments In The Pediatric Asthma Treatment Market

35. Pediatric Asthma Treatment Market High Potential Countries, Segments and Strategies

35.1 Pediatric Asthma Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Pediatric Asthma Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Pediatric Asthma Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer